Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026)
Fortrea Holdings (FTRE) reported Other Operating Expenses of $539.4 million for Q1 2026, down 48.61% on a YoY basis from $1.0 billion in Q1 2025, and down 5.55% quarter-over-quarter from $571.1 million in Q4 2025.
Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Other Operating Expenses for 5 years, with the latest figure at $539.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 48.61% year-over-year to $539.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (down 5.0% YoY), and the FY2025 full-year result was $3.1 billion, up 37.25% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $539.4 million, down from $571.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $1.0 billion in Q1 2025, with the low at $286.0 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $616.1 million across 5 years, with a median of $588.4 million in 2023.
- Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 109.58% — and 2026, when it slumped 48.61%.
- Fortrea Holdings' Other Operating Expenses stood at $286.0 million in 2022, then soared by 109.58% to $599.4 million in 2023, then gained by 0.85% to $604.5 million in 2024, then dropped by 5.53% to $571.1 million in 2025, then decreased by 5.55% to $539.4 million in 2026.
- The last three Other Operating Expenses figures came in at $539.4 million (Q1 2026), $571.1 million (Q4 2025), and $603.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 539.40 Mn |
| Dec 31, 2025 | 571.10 Mn |
| Sep 30, 2025 | 603.10 Mn |
| Jun 30, 2025 | 915.80 Mn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 604.50 Mn |
| Sep 30, 2024 | 556.60 Mn |
| Jun 30, 2024 | 557.10 Mn |
| Mar 31, 2024 | 579.40 Mn |
| Dec 31, 2023 | 599.40 Mn |
| Sep 30, 2023 | 585.10 Mn |
| Jun 30, 2023 | 591.80 Mn |
| Mar 31, 2023 | 563.00 Mn |
| Dec 31, 2022 | 286.00 Mn |
| Sep 30, 2022 | 617.50 Mn |
| Jun 30, 2022 | 637.70 Mn |